Literature DB >> 1250624

[Reduction of expected height in excessively tall boys (author's transl)].

H Frisch.   

Abstract

4 boys with familial tall stature aged 119/12-153/12 years were treated with Testosterone for reduction of definitive height by accelerating epiphyseal fusion. Body height at the beginning of therapy was 3,2-5,4 standard deviations over the mean, the height prediction was 199-205 cm. In therapy oral Methyltestosterone was used in the beginning and therapy was later continued with Testosterone oenanthate i.m. as depot preparation. The average duration of treatment was 14 months; in this time bone age was accelerated 2,3 times: a mean reduction of 8,9 cm from the predicted height was the result. No severe side effects could be observed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1250624

Source DB:  PubMed          Journal:  Padiatr Padol        ISSN: 0030-9338


  1 in total

1.  The results of short-term (6 months) high-dose testosterone treatment on bone age and adult height in boys of excessively tall stature.

Authors:  J H Brämswig; H J von Lengerke; H Schmidt; G Schellong
Journal:  Eur J Pediatr       Date:  1988-11       Impact factor: 3.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.